Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net:
Crude oil, natural gas, and NGL sales
Joint interest and other
Derivative assets
Prepaid income taxes
Deposits for acquisitions
Escrow Deposit
Prepaid expenses and other
Total current assets
Property and equipment (successful efforts method):
Proved properties
Less: accumulated depreciation, depletion, and amortization
Total proved properties, net
Unproved properties
Wells in progress
Other property and equipment, net of accumulated depreciation of $10 million in 2025 and $9 million in 2024
Total property and equipment, net
Derivative assets
Right-of-use assets
Deferred income tax assets
Other noncurrent assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses
Severance and ad valorem taxes payable
Crude oil, natural gas, and NGL revenue distribution payable
Derivative liability
Income tax payable
Asset retirement obligations
Lease liability
Deferred revenue
Deferred acquisition consideration
Other liabilities
Total current liabilities
Long-term liabilities:
Credit facility
Debt, net
Ad valorem taxes
Derivative liability
Deferred income tax liabilities, net
Asset retirement obligations
Lease liability
Deferred revenue
Other long-term liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $.01 par value, 25,000,000 shares authorized, none outstanding
Common stock, $.01 par value, 225,000,000 shares authorized, 85,293,095 and 93,933,857 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively
Additional paid-in capital
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support